• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.2% 黄原胶滴眼液治疗轻中度干眼后结膜上皮细胞的变化

Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye.

作者信息

Postorino Elisa Imelde, Aragona Pasquale, Rania Laura, Spinella Rosaria, Puzzolo Domenico, Micali Antonio, Mazza Anna Maria Livia, Papa Vincenzo

机构信息

Regional Referral Center for the Ocular Surface Diseases, Department of Biomedical Sciences, University of Messina, Messina, Italy.

Ophthalmology Unity, State Hospital of San Marino, Cailungo, Republic of San Marino.

出版信息

Eur J Ophthalmol. 2020 May;30(3):439-445. doi: 10.1177/1120672119833278. Epub 2019 Mar 11.

DOI:10.1177/1120672119833278
PMID:30852915
Abstract

PURPOSE

To study the effects of xanthan gum eye drops on the ocular surface and conjunctival cytology of patients with mild-moderate dry eye.

METHODS

This prospective, double-masked, controlled trial included 30 patients (age > 60 and Ocular Surface Disease Index score >12 and <33), divided into two groups of 15 subjects and treated with 0.2% xanthan gum eye drops (group 1) or 0.5% carboxymethylcellulose (group 2) qid. After a run-in period with saline qid, patients were evaluated by Ocular Surface Disease Index questionnaire, clinical assessment, and impression cytology at baseline (T0) and after 1 month (T1). For impression cytology, cellularity, cell-to-cell contacts, nucleus/cytoplasm ratio, chromatin aspect, goblet cells distribution, keratinization, and the presence of inflammatory cells were considered. Parameters were scored from 0 (no alterations) to 3 (evident alterations). For statistical analysis, Student's t-test, Wilcoxon rank-sum test, and Mann-Whitney U-test were used.

RESULTS

Clinically, after 1 month of treatment, group 1 showed an improvement of corneal stain (T0 = 1.1 ± 1.4; T1 = 0.5 ± 0.7; p = 0.03) and a reduction of Schirmer I test (T0 = 9.8 ± 6.1; T1 = 5.9 ± 4.1; p = 0.001). In group 2, no differences were found between T0 and T1 for all the clinical tests. For impression cytology, in group 1 cellularity (T0 = 0.6 ± 0.5; T1 = 0.3 ± 0.5; p = 0.05), chromatin aspect (T0 = 1.2 ± 0.4; T1 = 0.8 ± 0.5; p = 0.01), keratinization (T0 = 1 ± 0.7; T1 = 0.5 ± 0.5; p = 0.03), and total score (T0 = 5.8 ± 1.3; T1 = 3.6 ± 1.7; p = 0.003) were significantly ameliorated, while in group 2 only total score improved significantly (T0 = 5 ± 1.4; T1 = 4.3 ± 1.5; p = 0.01). The comparison between groups showed significant amelioration for keratinization in group 1 at T1 (p = 0.02).

CONCLUSION

The treatment with xanthan gum, a molecule with anti-oxidant and mucoadhesive properties, ameliorated conjunctival epithelium of mild-moderate dry eye patients better than carboxymethylcellulose.

摘要

目的

研究黄原胶滴眼液对轻中度干眼症患者眼表及结膜细胞学的影响。

方法

这项前瞻性、双盲、对照试验纳入了30例患者(年龄>60岁,眼表疾病指数评分>12且<33),分为两组,每组15名受试者,分别使用0.2%黄原胶滴眼液(第1组)或0.5%羧甲基纤维素(第2组),每日4次。在每日4次使用生理盐水的导入期后,患者在基线(T0)和1个月后(T1)通过眼表疾病指数问卷、临床评估和印片细胞学进行评估。对于印片细胞学,考虑细胞密度、细胞间接触、核质比、染色质形态、杯状细胞分布、角化以及炎症细胞的存在情况。参数评分从0(无改变)到3(明显改变)。对于统计分析,使用了学生t检验、Wilcoxon秩和检验和Mann-Whitney U检验。

结果

临床上,治疗1个月后,第1组角膜染色有所改善(T0 = 1.1±1.4;T1 = 0.5±0.7;p = 0.03),泪液分泌试验Ⅰ(Schirmer I test)降低(T0 = 9.8±6.1;T1 = 5.9±4.1;p = 0.001)。在第2组中,所有临床检查在T0和T1之间均未发现差异。对于印片细胞学,第1组的细胞密度(T0 = 0.6±0.5;T1 = 0.3±0.5;p = 0.05)、染色质形态(T0 = 1.2±0.4;T1 = 0.8±0.5;p = 0.01)、角化(T0 = 1±0.7;T1 = 0.5±0.5;p = 0.03)和总分(T0 = 5.8±1.3;T1 = 3.6±1.7;p = 0.003)均有显著改善,而在第2组中只有总分有显著改善(T0 = 5±1.4;T1 = 4.3±1.5;p = 0.01)。两组之间的比较显示,第1组在T1时角化有显著改善(p = 0.02)。

结论

黄原胶是一种具有抗氧化和黏膜黏附特性的分子,其治疗对轻中度干眼症患者结膜上皮的改善优于羧甲基纤维素。

相似文献

1
Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye.0.2% 黄原胶滴眼液治疗轻中度干眼后结膜上皮细胞的变化
Eur J Ophthalmol. 2020 May;30(3):439-445. doi: 10.1177/1120672119833278. Epub 2019 Mar 11.
2
Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.不含防腐剂的0.09%黄原胶/0.1%硫酸软骨素固定组合与聚乙二醇/丙二醇治疗干眼症受试者的疗效比较:一项多中心随机对照试验
BMC Ophthalmol. 2016 Sep 20;16(1):164. doi: 10.1186/s12886-016-0343-9.
3
Safety and Tolerability of an Eye Drop Based on 0.6% Povidone-Iodine Nanoemulsion in Dry Eye Patients.载碘纳米乳滴眼剂治疗干眼症的安全性和耐受性。
J Ocul Pharmacol Ther. 2021 Mar;37(2):90-96. doi: 10.1089/jop.2020.0085. Epub 2020 Dec 23.
4
Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.治疗干眼症患者新的润眼液滴眼剂配方的疗效。
J Ocul Pharmacol Ther. 2010 Aug;26(4):347-53. doi: 10.1089/jop.2010.0025.
5
An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.一项关于HP-瓜尔胶可凝胶化润滑眼药水改善中度干眼成年人群干眼体征和症状的开放标签评估。
Curr Med Res Opin. 2005 Feb;21(2):255-60. doi: 10.1185/030079905x26252.
6
[Efficacy of a recombinant bovine basic fibroblast growth factor gel for the treatment of moderate dry eye: a multicenter randomized double-blind parallel controlled clinical trial].重组牛碱性成纤维细胞生长因子凝胶治疗中度干眼症的疗效:一项多中心随机双盲平行对照临床试验
Zhonghua Yan Ke Za Zhi. 2021 Dec 11;57(12):930-938. doi: 10.3760/cma.j.cn112142-20201130-00784.
7
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.0.18%透明质酸钠治疗中度干眼综合征和浅层角膜炎患者的疗效与安全性。
Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. doi: 10.1007/s00417-004-1040-6. Epub 2004 Dec 17.
8
Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.干眼症患者结膜和角膜的印迹细胞学检查证实了鳞状化生与干眼临床严重程度之间的相关性。
Eur J Ophthalmol. 2003 Mar;13(2):115-27. doi: 10.1177/112067210301300201.
9
The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease.2%局部涂抹瑞巴派特治疗干眼疾病中结膜鳞状化生和杯状细胞密度的疗效。
J Ocul Pharmacol Ther. 2019 Jul/Aug;35(6):350-358. doi: 10.1089/jop.2018.0130. Epub 2019 Jun 28.
10
Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.3% 四水二喹法索对干眼症患者白内障手术后结膜表面及临床结果的影响
Int Ophthalmol. 2018 Oct;38(5):2021-2030. doi: 10.1007/s10792-017-0693-1. Epub 2017 Aug 18.

引用本文的文献

1
New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies.基于地奈德和黄原胶的新型眼药水制剂治疗干眼症的非临床研究
Pharmaceutics. 2025 Feb 12;17(2):235. doi: 10.3390/pharmaceutics17020235.
2
Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment.评估含黄原胶和低浓度磷酸地塞米松的眼科溶液治疗干眼病的观察性临床研究
Ophthalmol Ther. 2024 Oct;13(10):2559-2573. doi: 10.1007/s40123-024-01003-z. Epub 2024 Jul 26.
3
Effect of isolated intracranial hypertension on cerebral perfusion within the phase of primary disturbances after subarachnoid hemorrhage in rats.
大鼠蛛网膜下腔出血后原发性紊乱阶段孤立性颅内高压对脑灌注的影响。
Front Cell Neurosci. 2023 Jul 12;17:1115385. doi: 10.3389/fncel.2023.1115385. eCollection 2023.
4
Possible Strategies to Mitigate Placebo or Vehicle Response in Dry Eye Disease Trials: A Narrative Review.减轻干眼疾病试验中安慰剂或赋形剂反应的可能策略:一项叙述性综述
Ophthalmol Ther. 2023 Aug;12(4):1827-1849. doi: 10.1007/s40123-023-00720-1. Epub 2023 May 20.
5
Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability.含地塞米松/奈替米星的眼科水凝胶减少剂量以预防和治疗白内障手术后眼部炎症:疗效和耐受性。
Adv Ther. 2022 Dec;39(12):5474-5486. doi: 10.1007/s12325-022-02295-y. Epub 2022 Oct 7.
6
Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases.虾青素在眼科疾病中的研究进展及作用机制
J Ophthalmol. 2022 May 20;2022:8071406. doi: 10.1155/2022/8071406. eCollection 2022.